#br#


	2型糖尿病通过影响肠道菌群增加子痫前期的风险


	#br#

doi:10.3760/cma.j.cn441417-20250306-10001

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (10): 1586-1591.DOI: 10.3760/cma.j.cn441417-20250306-10001

• 妇产科专栏 • 下一篇

#br# 2型糖尿病通过影响肠道菌群增加子痫前期的风险 #br#

杨海燕¹ 宋沁雯² 王世丽¹ 吕尚伶¹ 陈晓芳¹ 秦莹²

¹烟台市烟台山医院产科，烟台 264000；²山东中医药大学附属医院产科，济南 250014

收稿日期:2025-03-06 出版日期:2025-05-15 发布日期:2025-05-21
通讯作者: 秦莹，Email：haoyunlucky2025@163.com
基金资助:
山东省中医药科技项目（Z-2023075）

Type 2 diabetes increases the risk of preeclampsia through alterations in gut microbiota

Yang Haiyan¹, Song Qinwen², Wang Shili¹, Lyu Shangling¹, Chen Xiaofang¹, Qin Ying²

¹Department of Obstetrics, Yantaishan Hospital, Yantai 264000, China; ²Department of Obstetrics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China

Received:2025-03-06 Online:2025-05-15 Published:2025-05-21
Contact: Qin Ying, Email: haoyunlucky2025@163.com
Supported by:
Project of Science and Technology of Traditional Chinese Medicine in Shandong Province (z-2023075)

摘要/Abstract

摘要：

目的　采用孟德尔随机化分析肠道菌群在糖尿病增加子痫前期风险中的中介作用。方法　本研究于2024年9月至11月在烟台市烟台山医院进行。从IEU OpenGWAS公开数据库中提取全基因组关联研究（Genome-Wide Association Studies，GWAS）数据，包括糖尿病（分别来自3个队列，样本量分别为461 578例、520 580例、659 316例）、子痫前期（118 291例）和子痫（11 729例）患者的单核苷酸多态性。使用两步法孟德尔随机化评估肠道菌群在糖尿病与子痫前期关系中的介导作用。211种肠道菌群的GWAS数据来自于14 306名欧洲参与者。采用MR-Egger回归截距和Cochran'sQ评估多效性和异质性，留一法进行敏感性分析。结果　1型糖尿病、2型糖尿病均与子痫前期风险增加相关［比值比（OR）=1.05、1.15］。在211种肠道菌群中，奥尔森菌属对子痫前期的效应值为0.12（P=0.003）；2型糖尿病对子痫前期的效应值为0.14（P=8.23E-05），奥尔森菌属与2型糖尿病、子痫前期均相关。孟德尔随机化显示，奥尔森菌属介导2型糖尿病对子痫前期风险有促进作用，占总效应的6%。结论　2型糖尿病通过肠道菌群增加子痫前期的发病风险。

关键词: 2型糖尿病； , , 子痫前期； , , 肠道菌群； , , 孟德尔随机化

Abstract:

Objective　To analyze the potential role of gut microbiota in elevating the risk of preeclampsia in individuals with diabetes by Mendelian randomization (MR). Methods　The study was carried out at Yantaishan Hospital from September to November 2024. The data of Genome-Wide Association Studies (GWAS) extracted from the IEU OpenGWAS public database. This study analyzed three large diabetic cohorts (n=461 578, 520 580, and 659 316), along with preeclampsia (n=118 291) and eclampsia (n=11 729) cohorts. The two-step MR method was employed to evaluate the mediating effect of gut microbiota on the relationship between diabetes and preeclampsia. Additionally, the GWAS data for gut microbiota included 211 taxa derived from 14 306 European participants. The MR-Egger regression intercept and Cochran's Q were used to evaluate the pleiotropy and heterogeneity. The sensitivity was analyzed by the leave-one-out method. Results　Types 1 and 2 diabetes were both associated with increased risk of preeclampsia (OR=1.05 and 1.15). Among the 211 gut microbiota taxa analyzed, the effect values of Olsenella for preeclampsia was 0.12 (P=0.003); the effect value of type 2 diabetes for preeclampsia was 0.14 (P=8.23E-05). Olsenella was related to type 2 diabetes and preeclampsia. The MR indicated that Olsenella partially mediated the effect of type 2 diabetes on preeclampsia, accounting for 6% of the total effect. Conclusion　Type 2 diabetes may increase the risk of preeclampsia via gut microbiota.

Key words: Type 2 diabetes, Preeclampsia, Gut microbiota, Mendelian randomization

杨海燕宋沁雯王世丽吕尚伶陈晓芳秦莹. #br# 2型糖尿病通过影响肠道菌群增加子痫前期的风险 #br# [J]. 国际医药卫生导报, 2025, 31(10): 1586-1591.

Yang Haiyan, Song Qinwen, Wang Shili, Lyu Shangling, Chen Xiaofang, Qin Ying.

Type 2 diabetes increases the risk of preeclampsia through alterations in gut microbiota [J]. International Medicine and Health Guidance News, 2025, 31(10): 1586-1591.

参考文献

[1]Weissgerber TL, Mudd LM. Preeclampsia and diabetes[J]. Curr Diab Rep, 2015,15(3):9. DOI: 10.1007/s11892-015-0579-4.

[2]Yerubandi S, Devi Kallur S, Gala A, et al. Eclampsia reduction with maternal early warning trigger tool[J]. Pregnancy Hypertens, 2024,35:6-11. DOI: 10.1016/j.preghy.2023.11.007.

[3]陈文清,管保章.糖尿病肾病合并妊娠研究进展[J].国际医药卫生导报,2024,30(1):15-20. DOI:10.3760/cma.j.issn.1007-1245.2024.01.003.

[4]Kaaja R, Laivuori H, Laakso M, et al. Evidence of a state of increased insulin resistance in preeclampsia[J]. Metabolism, 1999,48(7):892-896. DOI: 10.1016/s0026-0495(99)90225-1.

[5]Roberts JM.Endothelial dysfunction in preeclampsia[J]. Semin Reprod Endocrinol, 1998, 16(1):5-15.DOI:10.1055/s-2007-1016248.

[6]Solomon CG, Seely EW. Brief review: hypertension in pregnancy : a manifestation of the insulin resistance syndrome?[J]. Hypertension, 2001,37(2):232-239. DOI: 10.1161/01.hyp.37.2.232.

[7]Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies[J]. Hum Mol Genet, 2014,23(R1):R89-98. DOI: 10.1093/hmg/ddu328.

[8]Zhang T, Zhao JV, Schooling CM. The associations of plasma phospholipid arachidonic acid with cardiovascular diseases: a Mendelian randomization study[J]. EBioMedicine, 2021, 63:103189. DOI: 10.1016/j.ebiom.2020.103189.

[9]McCartney DL, Min JL, Richmond RC, et al. Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging[J]. Genome Biol, 2021,22(1):194. DOI: 10.1186/s13059-021-02398-9.

[10]Stender S, Kozlitina J, Nordestgaard BG, et al. Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci[J]. Nat Genet, 2017,49(6):842-847. DOI: 10.1038/ng.3855.

[11]Chiou J, Geusz RJ, Okino ML, et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics[J]. Nature, 2021,594(7863):398-402. DOI: 10.1038/s41586-021-03552-w.

[12]Xue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes[J]. Nat Commun, 2018,9(1):2941. DOI: 10.1038/s41467-018-04951-w.

[13]Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data[J]. Genet Epidemiol, 2013,37(7):658-665. DOI: 10.1002/gepi.21758.

[14]Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis[J]. JAMA, 2008,300(23):2754-2764. DOI: 10.1001/jama.2008.824.

[15]Vestgaard M, Sommer MC, Ringholm L, et al. Prediction of preeclampsia in type 1 diabetes in early pregnancy by clinical predictors: a systematic review[J]. J Matern Fetal Neonatal Med, 2018,31(14):1933-1939. DOI: 10.1080/14767058.2017.1331429.

[16]Takagi T, Naito Y, Kashiwagi S, et al. Changes in the gut microbiota are associated with hypertension, hyperlipidemia, and type 2 diabetes mellitus in Japanese subjects[J]. Nutrients, 2020,12(10):2996. DOI: 10.3390/nu12102996.

[17]Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults[J]. PLoS One, 2010,5(2):e9085. DOI: 10.1371/journal.pone.0009085.

[18]Sedighi M, Razavi S, Navab-Moghadam F, et al. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals[J]. Microb Pathog, 2017,111:362-369. DOI: 10.1016/j.micpath.2017.08.038.

[19]Koren O, Goodrich JK, Cullender TC, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy[J]. Cell, 2012,150(3):470-480. DOI: 10.1016/j.cell.2012.07.008.

[20]Lv LJ, Li SH, Wen JY, et al. Deep metagenomic characterization of gut microbial community and function in preeclampsia[J]. Front Cell Infect Microbiol, 2022,12:933523. DOI: 10.3389/fcimb.2022.933523.

[21]Chen X, Li P, Liu M, et al. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation[J]. Gut, 2020,69(3):513-522. DOI: 10.1136/gutjnl-2019-319101.

[22]Li P, Wang H, Guo L, et al. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study[J]. BMC Med, 2022,20(1):443. DOI: 10.1186/s12916-022-02657-x.

[23]Zhan Q, Qi X, Weng R, et al. Alterations of the human gut microbiota in intrahepatic cholestasis of pregnancy[J]. Front Cell Infect Microbiol, 2021,11:635680. DOI: 10.3389/fcimb.2021.635680.

[24]Wadhwani NS, Narang AS, Mehendale SS, et al. Reduced maternal erythrocyte long chain polyunsaturated fatty acids exist in early pregnancy in preeclampsia[J]. Lipids, 2016,51(1):85-94. DOI: 10.1007/s11745-015-4098-5.

[25]Xiong Z, Wang Q, Pei S, et al. The causal role of intestinal microbiome in development of pre-eclampsia[J]. Funct Integr Genomics, 2023,23(2):127. DOI: 10.1007/s10142-023-01054-8.

#br# 2型糖尿病通过影响肠道菌群增加子痫前期的风险 #br#

Type 2 diabetes increases the risk of preeclampsia through alterations in gut microbiota

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	赵洲刘为朋李宗睿王睿智胡宝光. 高血压大鼠模型的研究现状 [J]. 国际医药卫生导报, 2025, 31(9): 1465-1470.
[2]	吴亚莉付小平丁大为徐宁安周源源. 儿童注意缺陷多动障碍相关危险因素及预测模型构建 [J]. 国际医药卫生导报, 2025, 31(9): 1489-1494.
[3]	汪青园方元龙王智琴黄蓉田松原丽科葛午平朱小春肖尚杰周佳亮. 新生儿坏死性小肠结肠炎保守治疗后继发肠狭窄诊治分析 [J]. 国际医药卫生导报, 2025, 31(9): 1495-1498.
[4]	邓巧妮常亚娜周晓玉康华. 新生儿呼吸窘迫综合征机械通气撤机失败的预警模型构建 [J]. 国际医药卫生导报, 2025, 31(9): 1499-1505.
[5]	张森山蔡美孙锋. 新生儿ABO溶血病中血清总胆红素、脐血胆红素水平及网织红细胞计数对神经系统损害的预测价值 [J]. 国际医药卫生导报, 2025, 31(9): 1506-1510.
[6]	张珂刘景刚吴瑞荣冯慧. 局部枸橼酸钠联合小剂量肝素钠抗凝在脓毒症并急性肾损伤患者CRRT中的应用价值 [J]. 国际医药卫生导报, 2025, 31(9): 1516-1520.
[7]	臧柯靓班芳张秋梅张恒亮. 香丹注射液联合酒石酸美托洛尔对冠心病心绞痛患者临床症状及氧化应激反应的影响 [J]. 国际医药卫生导报, 2025, 31(9): 1520-1524.
[8]	江正发王立友张晓徐宏勇. 药物涂层球囊成形术后冠心病患者靶血管再狭窄的危险因素研究及预测模型分析 [J]. 国际医药卫生导报, 2025, 31(9): 1525-1531.
[9]	潘希安张远金张国富李俊孙法瑞刘炳霞. 人工智能技术在膝单髁置换术前规划中的应用分析 [J]. 国际医药卫生导报, 2025, 31(9): 1532-1537.
[10]	张婷郭淋张驰付瑞崔治权康晓刚. 青少年双相情感障碍患者血脂水平与区域性脑结构的相关性研究 [J]. 国际医药卫生导报, 2025, 31(9): 1538-1543.
[11]	李岩赵丽敏曲姗姗. 帕罗西汀联合茴拉西坦治疗老年抑郁症的疗效分析 [J]. 国际医药卫生导报, 2025, 31(9): 1544-1548.
[12]	杨玉凤卢立军邓倩陈士东王慧颖. 艾司西酞普兰联合舒肝解郁胶囊对老年抑郁症伴失眠的影响 [J]. 国际医药卫生导报, 2025, 31(9): 1549-1553.
[13]	潘祁喻莉张安生. 铸瓷嵌体冠在短基牙后牙修复患者中的应用效果 [J]. 国际医药卫生导报, 2025, 31(9): 1554-1558.
[14]	陈春桃区秀丽李彩霞刘彩玲曾娜芬杜真萍蔡少娜米谦符霞. 维持性血液透析患者自体动静脉内瘘瘤样扩张防治不足影响因素的质性研究 [J]. 国际医药卫生导报, 2025, 31(9): 1559-1564.
[15]	陈娟娟. 中线导管在住院病区患者静脉治疗中的应用现状 [J]. 国际医药卫生导报, 2025, 31(9): 1565-1568.